liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Efficient Seeding of Cerebral Vascular Ab-Amyloidosis by Recombinant AbM1-42 Amyloid Fibrils
Linköping University, Department of Physics, Chemistry and Biology, Chemistry. Linköping University, Faculty of Science & Engineering.ORCID iD: 0009-0002-1833-9697
Linköping University, Department of Physics, Chemistry and Biology, Chemistry. Linköping University, Faculty of Science & Engineering.
Linköping University, Department of Biomedical and Clinical Sciences, The Division of Cell and Neurobiology. Linköping University, Faculty of Medicine and Health Sciences. (Wallenberg Center for Molecular Medicine)ORCID iD: 0000-0002-3003-5509
Linköping University, Department of Physics, Chemistry and Biology, Chemistry. Linköping University, Faculty of Science & Engineering.ORCID iD: 0000-0002-4303-4783
Show others and affiliations
2025 (English)In: Journal of Molecular Biology, ISSN 0022-2836, E-ISSN 1089-8638, Vol. 437, no 3, article id 168923Article in journal (Refereed) Published
Abstract [en]

A(3-amyloid plaques and cerebral amyloid angiopathy (CAA) in the brain are pathological hallmarks of Alzheimer's disease (AD) and vascular dementia. The spreading of A(3 amyloidosis in the brain appears to be mediated by a seeding mechanism, where preformed fibrils (called seeds) accelerate A(3 fibril formation by bypassing the rate-determining nucleation step. Several studies have demonstrated that A(3 amyloidosis can be induced in transgenic mice, producing human A(3, by injecting A(3-rich brain extracts (seeds) derived from transgenic mice and human AD brains. However, studies on recombinant seeds are limited. Therefore, we investigated the seeding activity of pure recombinant human A(3 fibrils of different compositions. Seeds were inoculated into APP23 mice at the age of 3 months and were analyzed after 6 months of incubation. Recombinant fibril seeds made from A(3-peptides with an N-terminal methionine (i.e. (preformed fibrils from A(3M1-42, A(3M1-40, and A(3M1-40 +A(3M1-42) accelerated A(3-amyloid plaque formation in vivo compared to non-inoculated transgenic control mice of the same age. In addition, all seeds induced CAA pathology. Interestingly, A(3M1-42 containing seeds produced significantly more CAA and amyloid plaques than seeds containing pure A(3M1-40, which was surprising given that APP23 mice produce approximately four-fold more A(31-40 substrate than A(31-42. This study showed that A(3M1-42 fibrils are highly potent in seeding CAA and implies that conformational templating occurs in amyloid plaque as deduced by comparative amyloid ligand staining. Our results verify that recombinant A(3 fibrils are transmissible amyloids, and that in vivo seeding can accelerate, and redirect A(3 amyloidosis patterns compared to spontaneous age dependent amyloidosis. (c) 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Place, publisher, year, edition, pages
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD , 2025. Vol. 437, no 3, article id 168923
Keywords [en]
amyloid; seeding; Alzheimer's disease; transmissible amyloid; fluorescence
National Category
Medical Biotechnology (Focus on Cell Biology, (incl. Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
URN: urn:nbn:se:liu:diva-212040DOI: 10.1016/j.jmb.2024.168923ISI: 001421912100001PubMedID: 39725269Scopus ID: 2-s2.0-85213554064OAI: oai:DiVA.org:liu-212040DiVA, id: diva2:1942466
Note

Funding Agencies|Wallenberg Center of Molecular Medicine; Swedish Brain Foundation [ALZ2019-0004, ALZ2022-0004]; Swedish Research Council [2023-03931]; Gustav V and Drottning Viktorias Foundation

Available from: 2025-03-05 Created: 2025-03-05 Last updated: 2025-05-18

Open Access in DiVA

fulltext(4747 kB)162 downloads
File information
File name FULLTEXT01.pdfFile size 4747 kBChecksum SHA-512
02ff76b65fc6897aacc12eacdf9b244d7d710ddde54cb41336717017778d3169edfa0cf952a1ee0b79542e04554b352501c5902b7fe5dc59bb06c2b6e771cdd3
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Parvin, FarjanaLarsson, JohanJackson, WalkerNyström, SofieHammarström, Per
By organisation
ChemistryFaculty of Science & EngineeringThe Division of Cell and NeurobiologyFaculty of Medicine and Health Sciences
In the same journal
Journal of Molecular Biology
Medical Biotechnology (Focus on Cell Biology, (incl. Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar
Total: 162 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 215 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf